These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2163865)

  • 1. Brain dialysis and dopamine: does the extracellular concentration of dopamine reflect synaptic release?
    Pani L; Gessa GL; Carboni S; Portas CM; Rossetti ZL
    Eur J Pharmacol; 1990 May; 180(1):85-90. PubMed ID: 2163865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic L-DOPA-pretreatment of rats: an electrophysiological and biochemical study in the basal ganglia.
    Jackson DM; Walters JR; Miller LP
    Brain Res; 1982 Nov; 250(2):271-82. PubMed ID: 6129029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis.
    Zetterström T; Herrera-Marschitz M; Ungerstedt U
    Brain Res; 1986 Jun; 376(1):1-7. PubMed ID: 3087581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.
    Abercrombie ED; Bonatz AE; Zigmond MJ
    Brain Res; 1990 Aug; 525(1):36-44. PubMed ID: 2123121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amantadine increases L-DOPA-derived extracellular dopamine in the striatum of 6-hydroxydopamine-lesioned rats.
    Arai A; Kannari K; Shen H; Maeda T; Suda T; Matsunaga M
    Brain Res; 2003 May; 972(1-2):229-34. PubMed ID: 12711097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
    Schwarcz R; Fuxe K; Agnati LF; Hökfelt T; Coyle JT
    Brain Res; 1979 Jul; 170(3):485-95. PubMed ID: 37986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional damage of dopamine nerve terminals following intrastriatal kainic acid injection.
    Bonanno G; Fedele E; Versace P; Raiteri M
    Brain Res; 1989 Feb; 480(1-2):242-8. PubMed ID: 2713653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine behavioral toxicity: rotational behavior after chronic intrastriatal infusion.
    Dougherty GG; Ellinwood EH
    Biol Psychiatry; 1981 May; 16(5):479-88. PubMed ID: 7196774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin inhibition of apomorphine-induced circling in mice.
    Schwarz RD; Uretsky NJ; Bianchine JR
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1233-7. PubMed ID: 6819586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of morphine with apomorphine: behavioural and biochemical studies.
    Möller HG; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):452-7. PubMed ID: 3821935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.
    Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
    Brain Res; 1987 Jan; 401(2):322-30. PubMed ID: 3815099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice.
    Thornburg JE; Moore KE
    J Pharmacol Exp Ther; 1975 Jan; 192(1):42-9. PubMed ID: 1168250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat--an autoradiographic study.
    Gnanalingham KK; Robertson RG
    Brain Res; 1994 Mar; 640(1-2):185-94. PubMed ID: 8004447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic L-dopa treatment of rats and mice does not change the sensitivity of post-synaptic dopamine receptors.
    Jackson DM; Jenkins OF; Malor R; Christie MJ; Gregory P
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):271-4. PubMed ID: 6686648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of bradykinin on central dopamine receptors.
    Przesmycki K; Kleinrok Z
    Pol J Pharmacol Pharm; 1976; 28(6):673-8. PubMed ID: 1034925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolism of systemically-administered L-dihydroxyphenylalanine, by intact and dopamine-denervated striata, as revealed by brain microdialysis.
    Touchet N; Bennett JP
    Neuropharmacology; 1989 Nov; 28(11):1217-22. PubMed ID: 2594166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.